← Back to Search

ICG for Endometriosis

Q: Is this research endeavor currently accepting new participants?

Affirmatively, the data on clinicaltrials.gov indicates that this research trial is currently enrolling participants. The initial listing date was June 1st 2019 and it was most recently updated April 15th 2022.

Q: Is the age requirement for participation in this research restricted to octogenarians or younger?

Subjects aged 18 and below 50 years old are acceptable for this research project.

Q: How many individuals are currently engaged in this investigation?

Affirmative. Per the details on clinicaltrials.gov, this medical trial is still open to recruitment and was initially posted on June 1st 2019. Currently, 30 patients must be enrolled across one site before closure of enrolment can occur.

Q: Who can take part in this medical research project?

This medical experiment requires 30 individuals, aged 18 to 50 and diagnosed with endometrioma, to take part. In order for a patient to be eligible for the trial, they must have attended a preoperative visit at the Center for Comprehensive Gynecology and are due to undergo surgery.

Phase < 1

Waitlist Available

Led By Magdy Milad, MD,MS

Research Sponsored by Northwestern University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be between 18 and 65 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 2 years

Awards & highlights

Study Summary

This trial assessed whether dye could be used to better understand blood flow to ovaries during surgery.

Eligible Conditions

Endometriosis
Fibroid
Uterine Adenomyosis
Uterine Fibroids
Endometrial Cyst
Uterine Cyst

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 2 years

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~2 years

This trial's timeline: 3 weeks for screening, Varies for treatment, and 2 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Assessment of ovarian perfusion after ICG administration via fluorescent imaging

Trial Design

1Treatment groups

Experimental Treatment

Group I: Administration of ICGExperimental Treatment1 Intervention

ICG will be injected intravenously to assess ovarian perfusion in the presence or absence (control) of pathology. Near infrared fluorescence imaging will be used to illuminate the ICG. The extent of perfusion will be determined using digital imaging software. ICG will be stored at the NM Investigational Pharmacy and administered intravenously by the anesthesiologist at the direction of the surgeon during surgical procedure.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

ICG

2014

Completed Phase 1

~580

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Northwestern UniversityLead Sponsor

1,585 Previous Clinical Trials

917,177 Total Patients Enrolled

2 Trials studying Endometriosis

425 Patients Enrolled for Endometriosis

Magdy Milad, MD,MSPrincipal Investigator - Northwestern University

Central DuPage Hospital, Northwestern Lake Forest Hospital, Northwestern Memorial Hospital

Wayne State University School Of Medicine (Medical School)

Mayo Grad School Med/Mayo Fndn (Residency)

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this research endeavor currently accepting new participants?

"Affirmatively, the data on clinicaltrials.gov indicates that this research trial is currently enrolling participants. The initial listing date was June 1st 2019 and it was most recently updated April 15th 2022."

Answered by AI

Is the age requirement for participation in this research restricted to octogenarians or younger?

"Subjects aged 18 and below 50 years old are acceptable for this research project."

Answered by AI

How many individuals are currently engaged in this investigation?

"Affirmative. Per the details on clinicaltrials.gov, this medical trial is still open to recruitment and was initially posted on June 1st 2019. Currently, 30 patients must be enrolled across one site before closure of enrolment can occur."

Answered by AI

Who can take part in this medical research project?

"This medical experiment requires 30 individuals, aged 18 to 50 and diagnosed with endometrioma, to take part. In order for a patient to be eligible for the trial, they must have attended a preoperative visit at the Center for Comprehensive Gynecology and are due to undergo surgery."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

ICG to Assess Ovarian Perfusion

Magdy Milad, MD 2019. "ICG to Assess Ovarian Perfusion". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03927651.